Summit Partners Public Asset Management’s Treace Medical Concepts TMCI Stock Holding History

Summit Partners Public Asset Management’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-391,869	Closed	-$10M	–	186
2023 Q2	$10M	Sell	391,869 -363,510	-48%	-$9.38M	0.37%	79
2023 Q1	$19M	Buy	755,379 +262,166	+53%	+$6.16M	0.78%	49
2022 Q4	$11.3M	Buy	493,213 +8,127	+2%	+$187K	0.72%	47
2022 Q3	$10.7M	Buy	+485,086	New	+$9.38M	0.55%	61

Other funds holding TMCI

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Summit Partners Public Asset Management's TMCI Position: Q3 2023 in Review

Summit Partners Public Asset Management sold out of Treace Medical Concepts (TMCI) in Q3 2023, closing a stake of 391,869 shares — an estimated $10M sold.

Summit Partners Public Asset Management first reported a position in TMCI in Q3 2022 and held it in 4 quarters. The position peaked at $19M in Q1 2023. 123 funds tracked by Wall St. Rank hold TMCI as of Q3 2023.

Summit Partners Public Asset Management reported no remaining Treace Medical Concepts position as of Q3 2023 after selling out during the quarter.
Summit Partners Public Asset Management sold 391,869 Treace Medical Concepts shares in Q3 2023, an estimated $10M.
Summit Partners Public Asset Management first reported a position in Treace Medical Concepts in Q3 2022 and held it in 4 quarters.
Summit Partners Public Asset Management's Treace Medical Concepts position peaked at $19M in Q1 2023.
123 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2023.

Based on Summit Partners Public Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.